Alan Packer joined the Simons Foundation in 2009 as an associate director of research. He earned his undergraduate degree in biology from Brandeis University and his Ph.D. in cell biology and genetics from the Weill Cornell Graduate School of Medical Sciences in New York City. His graduate work with Rosemary Bachvarova focused on germ cell development using the mouse as a model system. With Debra Wolgemuth at the Columbia University College of Physicians and Surgeons, he carried out postdoctoral work on developmental control genes (HOX genes) and the mechanisms of their regulation in the mouse embryo. In 2000, Packer joined the editorial staff of Nature Genetics, the leading journal in the field of genetics, where he was involved in all aspects of the journal’s production. His responsibilities included overseeing peer review of submitted manuscripts, with an emphasis on the genetics of human disease, as well as commissioning reviews, writing press releases and editorials, updating the journal’s website, and preparing special issues of the journal. He served as acting editor in 2002-2003. During his tenure at Nature Genetics, he established a wide range of contacts in the genetics community through attendance at meetings and visits with scientists in their labs. Packer has also done freelance writing on a number of topics for Nature and other scientific publications.
Alan Packer
From this contributor
Startled fish help sound out sensory overload in autism
There is some evidence that neural habituation — the process by which neurons get used to sensory stimuli — goes awry in autism. Mutant fish may help us understand the sensory sensitivities that often accompany the disorder, says Alan Packer.
Startled fish help sound out sensory overload in autism
Study uncovers link between autism risk gene, language
Mutations in TBR1, a candidate gene for autism, compromise its functions and its ability to bind its partners — including FOXP2. Alan Packer explores the gene’s emerging link to language.
Study uncovers link between autism risk gene, language
Schizophrenia milestone holds lessons for autism
A long-awaited report, published today in Nature, confirms that with access to tens of thousands of genomes, researchers can identify common genetic risk factors for a complex neuropsychiatric disorder.
Multimodal mouse model for autism
A new paper accomplishes a rare feat, linking human genetics with physiology, behavior and a therapeutic in a compelling mouse model of autism, says Alan Packer.
Keeping score
An effort to rank autism genes on the strength of the evidence implicating them in the disorder will provide researchers with a focused list of genes to study, says Alan Packer.
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.